BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8304162)

  • 1. Mutations of human dihydrofolate reductase causing decreased inhibition by methotrexate.
    Blakley RL; Appleman JR; Chunduru SK; Nakano T; Lewis WS; Harris SE
    Adv Exp Med Biol; 1993; 338():473-9. PubMed ID: 8304162
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetic investigation of methotrexate resistant human dihydrofolate reductase (hDHFR) mutants at Phe31.
    Chunduru SK; Appleman JR; Blakley RL
    Adv Exp Med Biol; 1993; 338():507-10. PubMed ID: 8304168
    [No Abstract]   [Full Text] [Related]  

  • 3. Methotrexate-insensitive mutants of human dihydrofolate reductase (hDHFR) constructed by site-directed mutagenesis at phenylalanine 34.
    Nakano T; Appleman JR; Blakley RL
    Adv Exp Med Biol; 1993; 338():503-5. PubMed ID: 8304167
    [No Abstract]   [Full Text] [Related]  

  • 4. Site-directed mutagenesis of mouse dihydrofolate reductase. Mutants with increased resistance to methotrexate and trimethoprim.
    Thillet J; Absil J; Stone SR; Pictet R
    J Biol Chem; 1988 Sep; 263(25):12500-8. PubMed ID: 3045118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of codon 22 mutations on substrate and inhibitor binding for human dihydrofolate reductase.
    Ercikan E; Waltham M; Dicker A; Schweitzer B; Bertino JR
    Adv Exp Med Biol; 1993; 338():515-9. PubMed ID: 8304170
    [No Abstract]   [Full Text] [Related]  

  • 6. Methotrexate-resistant variants of human dihydrofolate reductase with substitutions of leucine 22. Kinetics, crystallography, and potential as selectable markers.
    Lewis WS; Cody V; Galitsky N; Luft JR; Pangborn W; Chunduru SK; Spencer HT; Appleman JR; Blakley RL
    J Biol Chem; 1995 Mar; 270(10):5057-64. PubMed ID: 7890613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling enzyme inhibition using an expanded set of genetically encoded amino acids.
    Zheng S; Kwon I
    Biotechnol Bioeng; 2013 Sep; 110(9):2361-70. PubMed ID: 23568807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonadditivity of mutational effects at the folate binding site of Escherichia coli dihydrofolate reductase.
    Huang Z; Wagner CR; Benkovic SJ
    Biochemistry; 1994 Sep; 33(38):11576-85. PubMed ID: 7918371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate binding to dihydrofolate reductase from a methotrexate-resistant strain of Escherichia coli.
    Williams MN; Poe M; Greenfield NJ; Hirshfield JM; Hoogsteen K
    J Biol Chem; 1973 Sep; 248(18):6375-9. PubMed ID: 4147159
    [No Abstract]   [Full Text] [Related]  

  • 10. Does R67 dihydrofolate reductase possess a proton donor?
    Holland JC; Linn CE; DiGiammarino E; Nichols R; Howell EE
    Adv Exp Med Biol; 1993; 338():493-8. PubMed ID: 8304165
    [No Abstract]   [Full Text] [Related]  

  • 11. High throughput screening identifies novel inhibitors of Escherichia coli dihydrofolate reductase that are competitive with dihydrofolate.
    Zolli-Juran M; Cechetto JD; Hartlen R; Daigle DM; Brown ED
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2493-6. PubMed ID: 12852950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active site-directed double mutants of dihydrofolate reductase.
    Ercikan-Abali EA; Mineishi S; Tong Y; Nakahara S; Waltham MC; Banerjee D; Chen W; Sadelain M; Bertino JR
    Cancer Res; 1996 Sep; 56(18):4142-5. PubMed ID: 8797582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of phenylalanine 34 of human dihydrofolate reductase in substrate and inhibitor binding and in catalysis.
    Nakano T; Spencer HT; Appleman JR; Blakley RL
    Biochemistry; 1994 Aug; 33(33):9945-52. PubMed ID: 8061003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 11-oxahomofolate and its reduced derivatives on human dihydrofolate reductase and on human cells having different amounts of dihydrofolate reductase.
    Domin BA; Cheng YC; Nair MG
    Biochem Pharmacol; 1982 Jan; 31(2):255-6. PubMed ID: 7059366
    [No Abstract]   [Full Text] [Related]  

  • 15. Transfection of DHFR- and DHFR+ mammalian cells using methotrexate-resistant mutants of mouse dihydrofolate reductase.
    Thillet J; Pictet R
    FEBS Lett; 1990 Sep; 269(2):450-3. PubMed ID: 2401371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of conversion of phenylalanine-31 to leucine on the function of human dihydrofolate reductase.
    Prendergast NJ; Appleman JR; Delcamp TJ; Blakley RL; Freisheim JH
    Biochemistry; 1989 May; 28(11):4645-50. PubMed ID: 2765506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of oxidised folates by dihydrofolate reductase from methotrexate-resistant Lactobacillus casei.
    McIntyre LJ; Harding NG
    Biochim Biophys Acta; 1977 Jun; 482(2):261-71. PubMed ID: 18181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of methotrexate binding to dihydrofolate reductase by dihydrofolate. Studies with pure enzyme and computer modeling using network thermodynamics.
    White JC
    J Biol Chem; 1979 Nov; 254(21):10889-95. PubMed ID: 387759
    [No Abstract]   [Full Text] [Related]  

  • 19. 2-tier bacterial and in vitro selection of active and methotrexate-resistant variants of human dihydrofolate reductase.
    Fossati E; Volpato JP; Poulin L; Guerrero V; Dugas DA; Pelletier JN
    J Biomol Screen; 2008 Jul; 13(6):504-14. PubMed ID: 18566481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two different effects of mutation on the binding of folate antagonists by a microbial dihydrofolate reductase.
    Sirotnak FM
    Biochim Biophys Acta; 1973 Mar; 302(1):13-23. PubMed ID: 4144236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.